×
Intradiscal injection of SB-01 in patients with degenerative disc disease was developed as a first-in-class approach to potentially treating chronic back ...
People also ask
SB-01 treatment consists of a single intradiscal injection of the diseased disc and antagonizes the overexpression of TGFβ1, which decreases inflammation, pain ...
The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and related ...
May 11, 2022 · SB-01 treatment consists of a single intradiscal injection of the diseased disc and antagonizes the overexpression of TGFβ1, which decreases ...
May 3, 2024 · SB-01 is under development for the treatment of degenerative disc disease (DDD) and chronic low back pain. The drug candidate is administered as ...
May 11, 2022 · SB-01 treatment consists of a single intradiscal injection of the diseased disc and antagonizes the overexpression of TGFβ1, which decreases ...
The results of this pilot study suggest that intradiscal injection therapy with glucosamine, chondroitin sulfate, hypertonic dextrose and DMSO warrants ...
Mar 31, 2024 · The purpose of the study is to confirm the safety and effectiveness of SB-01 For Injection in adult patients with chronic low back pain and ...
SB-01 is under development for the treatment of degenerative disc disease (DDD) and low back pain. The drug candidate is administered as an intradiscal ...
Sep 7, 2022 · SB-01 treatment consists of a single intradiscal injection of the diseased disc and antagonizes the overexpression of TGFβ1, which decreases ...